112 related articles for article (PubMed ID: 8106287)
21. [UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects].
Kato H; Inoue S; Takahashi K; Yamanaka A; Okada Y
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1866-70. PubMed ID: 3036016
[TBL] [Abstract][Full Text] [Related]
22. Metabolic and distribution studies with radiolabeled 5-fluorouracil.
Young D; Vine E; Ghanbarpour A; Shani J; Siemsen JK; Wolf W
Nuklearmedizin; 1982 Feb; 21(1):1-7. PubMed ID: 6281741
[TBL] [Abstract][Full Text] [Related]
23. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
Suzuki M; Sekiguchi I; Ohwada M; Tamada T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435
[TBL] [Abstract][Full Text] [Related]
24. Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer--in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase.
Inoue K; Takao M; Watanabe F; Tarukawa T; Shimamoto A; Kaneda M; Sakai T; Fukushima M; Shimpo H; Yada I
Lung Cancer; 2005 Jul; 49(1):47-54. PubMed ID: 15949589
[TBL] [Abstract][Full Text] [Related]
25. Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.
Kato T; Shimamoto Y; Uchida J; Ohshimo H; Abe M; Shirasaka T; Fukushima M
Anticancer Res; 2001; 21(3B):1705-12. PubMed ID: 11497250
[TBL] [Abstract][Full Text] [Related]
26. 5-Fluorouracil is converted to F-nucleotides more extensively and is more cytotoxic in poorly differentiated than in well differentiated human gastric carcinoma.
Maehara Y; Kusumoto T; Emi Y; Anai H; Sakaguchi Y; Kohnoe S; Sugimachi K
Anticancer Res; 1990; 10(4):1091-4. PubMed ID: 2382981
[TBL] [Abstract][Full Text] [Related]
27. Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.
Takechi T; Okabe H; Ikeda K; Fujioka A; Nakagawa F; Ohshimo H; Kitazato K; Fukushima M
Oncol Rep; 2005 Jul; 14(1):33-9. PubMed ID: 15944764
[TBL] [Abstract][Full Text] [Related]
28. [The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil].
Yamashita K; Mitani K; Morishita Y; Inoue K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):767-73. PubMed ID: 2496666
[TBL] [Abstract][Full Text] [Related]
29. A pilot study of mRNA expressions of 5-fluorouracil pathway genes in peripheral blood mononuclear cells and tumor tissues in patients with lung adenocarcinoma.
Ogata S; Ozeki Y; Nakanishi K; Fujita Y; Tanaka F; Hasegawa S; Mio T; Wada H; Hiroi S; Tominaga S; Aida S; Takeuchi K; Kawai T
Lung Cancer; 2011 Feb; 71(2):199-204. PubMed ID: 20494472
[TBL] [Abstract][Full Text] [Related]
30. Development of new promising antimetabolite, DFP-11207 with self-controlled toxicity in rodents.
Fukushima M; Iizuka K; Jin C; Zhang C; Hong M; Eshima K
Drug Des Devel Ther; 2017; 11():1693-1705. PubMed ID: 28652707
[TBL] [Abstract][Full Text] [Related]
31. [Expression of glypican-3 in lung squamous cell carcinoma and adenocarcinoma and its relation with prognosis].
Li H; Deng Q; Huang L; Tang H; Cheng X
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):212-5. PubMed ID: 23443774
[TBL] [Abstract][Full Text] [Related]
32. Dihydropyrimidine dehydrogenase levels in nonsmall-cell lung cancer tissues.
Yano T; Koga T; Ninomiya S; Takeo S
Int J Clin Oncol; 2002 Dec; 7(6):361-4. PubMed ID: 12494252
[TBL] [Abstract][Full Text] [Related]
33. Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver.
Komatsu T; Yamazaki H; Shimada N; Nagayama S; Kawaguchi Y; Nakajima M; Yokoi T
Clin Cancer Res; 2001 Mar; 7(3):675-81. PubMed ID: 11297264
[TBL] [Abstract][Full Text] [Related]
34. [Distribution pattern of fibronectin in human lung cancer tissue].
Ohhashi M; Usuda N; Sugenoya A; Adati W; Morimoto M; Nagata T; Iida F
Gan No Rinsho; 1986 Nov; 32(14):1787-94. PubMed ID: 3795499
[TBL] [Abstract][Full Text] [Related]
35. The combined antitumour effect of a new 5-fluorouracil derivative, BOF-A2, and radiation in vivo.
Murata R; Shibamoto Y; Miyauchi S; Hirohashi M; Takagi T; Sasai K; Oya N; Hiraoka M
Br J Cancer Suppl; 1996 Jul; 27():S114-6. PubMed ID: 8763861
[TBL] [Abstract][Full Text] [Related]
36. Other fluorinated pyrimidines in the treatment of solid tumors.
Saad ED; Hoff PM
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):65-8. PubMed ID: 11219980
[TBL] [Abstract][Full Text] [Related]
37. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
[TBL] [Abstract][Full Text] [Related]
38. [Significance of caveolin-1 expression in primary lung cancer].
Yu JH; Wei Q; Qi FJ; Xu HT; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):664-8. PubMed ID: 17374210
[TBL] [Abstract][Full Text] [Related]
39. Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats.
Yoshisue K; Hironaga K; Yamaguchi S; Yamamoto A; Nagayama S; Kawaguchi Y
Cancer Chemother Pharmacol; 2000; 46(1):51-6. PubMed ID: 10912578
[TBL] [Abstract][Full Text] [Related]
40. Effect of uracil on metabolism of 5-fluorouracil in vitro.
Ikenaka K; Shirasaka T; Kitano S; Fujii S
Gan; 1979 Jun; 70(3):353-9. PubMed ID: 467897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
